Concurrence of EGFR amplification and sensitizing mutations indicate a better survival benefit from EGFR-TKI therapy in lung adenocarcinoma patients
Shan, Ling, Wang, Ziping, Guo, Lei, Sun, Hongyan, Qiu, Tian, Ling, Yun, Li, Wenbin, Li, Lin, Liu, Xiuyun, Zheng, Bo, Lu, Ning, Ying, JianmingVolume:
89
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2015.06.008
Date:
September, 2015
File:
PDF, 947 KB
english, 2015